Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Shapely vs NovoCare Pharmacy

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Shapely logo

Shapely

7.3
★★★3.7

Best for: Insurance-accepted telehealth with compounded sema $99/mo and tirz $166/mo; CA, FL, NY, TX (expanding)

Visit Shapely
VS
NovoCare Pharmacy logo

NovoCare Pharmacy

8.7
★★★★4.4

Best for: branded Wegovy at the lowest manufacturer-direct self-pay price

Visit NovoCare Pharmacy

Shapely and NovoCare Pharmacy are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, Shapely starts lower at $99/mo versus $149/mo, and NovoCare Pharmacy edges ahead overall (8.7 vs 7.3 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.

Pricing

Shapely

Starter dose (lowest titration)Compounded
$99/mo
semaglutide

Verbatim from semaglutide medication page: 'Starting at $99/month'. Starter 3-month supply at lowest titration dose ($297/quarter). Tiered: ~$139/mo (low-mid dose), ~$179/mo (high dose). Free 2-day shipping; syringes and alcohol pads included. Via state-licensed 503A/503B compounding pharmacy. A separate telehealth recurring plan ($99/mo, $49 first-month promo) is required in addition to the medication cost.

Starter dose (lowest titration)Compounded
$166/mo
tirzepatide

Verbatim from tirzepatide medication page: 'Starting at $166/month'. Starter dose at lowest titration. Tiered: ~$249/mo (low-mid dose), ~$299/mo (high dose). Free 2-day shipping; syringes and alcohol pads included. Via state-licensed 503A/503B compounding pharmacy. Self-pay only for compounded tirz. A separate telehealth recurring plan ($99/mo, $49 first-month promo) is required in addition to the medication cost.

NovoCare Pharmacy

Wegovy pill (oral semaglutide tablets, 1.5 mg / 4 mg)oral
$149/mo
semaglutide

$149/mo for 1.5 mg and 4 mg new self-pay; 4 mg offer ends 8/31/2026, then $199/mo for 4 mg

Wegovy pen 0.25-2.4 mg (standard self-pay)Brand-name
$349$199/mo
Save 43% right now
semaglutide

$199/mo intro = first 2 monthly fills (0.25/0.5 mg) for patients new to the offer/pharmacy, through 6/30/2026; then $349/mo standard

Wegovy HD pen 7.2 mg (high-dose self-pay)Brand-name
$399/mo
semaglutide
Wegovy with commercial insurance (copay)Brand-name
$25/mo
semaglutide

with commercial insurance, as little as $25/mo; subject to max savings of $100/month

What’s included

Shapely

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Billed separately

Coaching

Included

NovoCare Pharmacy

Inclusions not disclosed.

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

Shapely

7.3/10

Overall

NovoCare Pharmacy

8.7/10

Value25%

7.5A
vs
B
8.5

Effectiveness25%

7.5A
vs
B
9.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.0A
vs
B
9.5

Accessibility10%

4.5A
vs
B
9.0

Support10%

8.0A
vs
B
8.0

Features & Coverage

FeatureShapelyNovoCare Pharmacy
Starting Price$99/mo$149/mo
Features8 features5 features
States Available450
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

About Shapely

Shapely is a GLP-1 telehealth platform founded by Dr. Justin Zaghi, MD/MBA, a Harvard-trained physician board-certified in both internal medicine and obesity medicine. The service accepts major PPO insurance and Medicare for brand-name GLP-1s including Wegovy, Ozempic, Zepbound, and Mounjaro, while offering compounded semaglutide from $99/month and compounded tirzepatide from $166/month for self-pay patients — both with free 2-day shipping and supplies included via state-licensed 503A/503B pharmacies.

Read our full Shapely review →

About NovoCare Pharmacy

Novo Nordisk's first-party direct-to-consumer pharmacy for branded Wegovy (semaglutide). Manufacturer-owned channel: Wegovy 0.25 mg / 0.5 mg starter doses at $199/month through 6/30/2026; full-dose Wegovy at $349/month standard self-pay; Wegovy HD at $399/month. Ships nationwide. Distinct from telehealth platforms that route Wegovy through NovoCare — this is the manufacturer pharmacy itself.

Read our full NovoCare Pharmacy review →

Pros & Cons

Shapely

What we like

  • Founded by Dr. Justin Zaghi, MD/MBA — Harvard-trained, board-certified in internal medicine and obesity medicine, with Medical Director Ana Lisa
  • Brand-name GLP-1s (Wegovy, Ozempic, Zepbound, Mounjaro, Foundayo) covered by major PPO and Medicare at copay
  • Compounded semaglutide from $99/month with free 2-day shipping, syringes, and supplies included via 503A/503B pharmacy
  • 1:1 registered dietitian (RDN) and monthly video provider visits included in every plan; unlimited chat and app support
  • Cellular smart scale provided to qualifying patients for ongoing weight tracking throughout the program

Watch-outs

  • Currently available only in California, Florida, New York, and Texas — 46 states unserved despite announced expansion
  • Telehealth subscription ($99/mo self-pay, $49 first-month promo) is charged separately from compounded medication cost
  • Labs not included — $75 flat rate for uninsured patients; baseline bloodwork may be required before prescribing
  • No LegitScript certification found on any public page
  • Compounding pharmacy partner not named publicly; 503A/503B status claimed but specific pharmacy undisclosed

NovoCare Pharmacy

What we like

  • First-party Novo Nordisk pharmacy — the most authoritative branded Wegovy channel
  • $199/mo intro pricing on Wegovy 0.25/0.5 mg starter doses (through 6/30/2026), the lowest brand self-pay price
  • $349/mo standard self-pay is well below the ~$1,300/mo retail list price
  • Ships to all 50 states with no telehealth-platform middleman fees
  • Cold-chain logistics handled directly by Novo Nordisk
  • Insurance-billing path available via the NovoCare savings program
  • NEW $149/mo Wegovy pill (oral semaglutide tablets, 1.5/4 mg) self-pay tier — 4 mg rises to $199/mo after 8/31/2026

Watch-outs

  • Wegovy only — no Ozempic, no tirzepatide, no compounded GLP-1
  • Requires an existing Wegovy prescription — no prescribing clinicians or telehealth intake
  • No clinical support included — your own prescriber handles titration and side effects
  • Manufacturer-set pricing can change at any time
  • $199 pen intro covers only the first 2 fills for new patients (through 6/30/2026); maintenance doses are $349/mo ($399 HD)

Our Verdict

Winner: NovoCare Pharmacy

NovoCare Pharmacy edges out Shapely with a higher overall score of 8.7/10 and is particularly strong for branded Wegovy at the lowest manufacturer-direct self-pay price. Shapely remains a solid alternative, especially if you're looking for Insurance-accepted telehealth with compounded sema $99/mo and tirz $166/mo; CA, FL, NY, TX (expanding).

Choose Shapely if…

You want Insurance-accepted telehealth with compounded sema $99/mo and tirz $166/mo; CA, FL, NY, TX (expanding) and a starting price around $99/mo.

Choose NovoCare Pharmacy if…

You want branded Wegovy at the lowest manufacturer-direct self-pay price and a starting price around $149/mo.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online, ranked by our editorial score.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.8

Gala

Compounded GLP-1/GIP combo therapy on a yearly subscription with free shipping nationwide

7.7

Trimi Health

Budget-conscious shoppers

8.6

Enhance MD

Lab-monitored compounded GLP-1 with mandatory video visit

Shapely vs NovoCare Pharmacy: FAQ

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Related comparisons

Continue exploring Shapely and NovoCare Pharmacy head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.